Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression-Reference-Cited by-同舟云学术

Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression

Published:2011-12-19 Issue:43 Volume:31 Page:4599-4608
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Pareja F,Ferraro D A,Rubin C,Cohen-Dvashi H,Zhang F,Aulmann S,Ben-Chetrit N,Pines G,Navon R,Crosetto N,Köstler W,Carvalho S,Lavi S,Schmitt F,Dikic I,Yakhini Z,Sinn P,Mills G B,Yarden Y

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2011587.pdf

Reference40 articles.

1. Avraham R, Yarden Y . Feedback regulation of EGFR signalling: decision making by early and delayed loops. Nat Rev Mol Cell Biol 2010; 12: 104–117.

2. Sorkin A, von Zastrow M . Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol 2009; 10: 609–622.

3. Goh LK, Huang F, Kim W, Gygi S, Sorkin A . Multiple mechanisms collectively regulate clathrin-mediated endocytosis of the epidermal growth factor receptor. J Cell Biol 2010; 189: 871–883.

4. Fehrenbacher N, Bar-Sagi D, Philips M . Ras/MAPK signaling from endomembranes. Mol Oncol 2009; 3: 297–307.

5. Vieira AV, Lamaze C, Schmid SL . Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 1996; 274: 2086–2089.

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP21-EGFR signaling axis is functionally implicated in metastatic colorectal cancer;2024-08-10

2. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches;Molecular Cancer;2024-07-25

3. Recent Advances in the Importance of Ubiquitylation for Receptor Internalization and Signaling;Physiology;2024-05-20

4. Emerging roles of deubiquitinating enzymes in actin cytoskeleton and tumor metastasis;Cellular Oncology;2024-02-07

5. OTUD7B knockdown inhibits the proliferation and stemness of breast cancer cells by destabilizing FOXM1;Oncology Letters;2024-01-16